Molecular Biology of the Cell click for CBE Life Science Education Page

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Originally published as MBC in Press, 10.1091/mbc.E08-03-0291 on July 30, 2008

Vol. 19, Issue 10, 4238-4248, October 2008

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Materials
Right arrow All Versions of this Article:
E08-03-0291v1
19/10/4238    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Maubach, G.
Right arrow Articles by Zhuo, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Maubach, G.
Right arrow Articles by Zhuo, L.

Nuclear Cathepsin F Regulates Activation Markers in Rat Hepatic Stellate Cells

Gunter Maubach, Michelle Chin Chia Lim, and Lang Zhuo

Department of Tissue Engineering, Institute of Bioengineering and Nanotechnology, Singapore 138669

Submitted March 18, 2008; Revised July 14, 2008; Accepted July 23, 2008
Monitoring Editor: William P. Tansey

Activation of hepatic stellate cells during liver fibrosis is a major event facilitating an increase in extracellular matrix deposition. The up-regulation of smooth muscle {alpha}-actin and collagen type I is indicative of the activation process. The involvement of cysteine cathepsins, a class of lysosomal cysteine proteases, has not been studied in conjunction with the activation process of hepatic stellate cells. Here we report a nuclear cysteine protease activity partially attributed to cathepsin F, which co-localizes with nuclear speckles. This activity can be regulated by treatment with retinol/palmitic acid, known to reduce the hepatic stellate cell activation. The treatment for 48 h leads to a decrease in activity, which is coupled to an increase in cystatin B and C transcripts. Cystatin B knockdown experiments during the same treatment confirm the regulation of the nuclear activity by cystatin B. We demonstrate further that the inhibition of the nuclear activity by E-64d, a cysteine protease inhibitor, results in a differential regulation of smooth muscle {alpha}-actin and collagen type I transcripts. On the other hand, cathepsin F small interfering RNA transfection leads to a decrease in nuclear activity and a transcriptional down-regulation of both activation markers. These findings indicate a possible link between nuclear cathepsin F activity and the transcriptional regulation of hepatic stellate cell activation markers.


This was published online ahead of print in MBC in Press (http://www.molbiolcell.org/cgi/doi/10.1091/mbc.E08-03-0291) on July 30, 2008.

Address correspondence to: Gunter Maubach (gmaubach{at}ibn.a-star.edu.sg) or Lang Zhuo (lzhuo{at}ibn.a-star.edu.sg)

Abbreviations used: CMK, chloromethyl ketone; DTT, dithiothreitol; GFAP, glial fibrillary acidic protein; HSC, hepatic stellate cell; IF, immunofluorescence; LHVS, N-morpholinurea-leucine-homophenyl alanine-vinylsulfone-phenyl; MCA, 4-methylcoumaryl-7-amide; PDI, protein disulfide isomerase; PFA, paraformaldehyde; RAR, retinoic acid receptor; SMAA, smooth muscle {alpha}-actin; TESS, transcription element search software.







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Copyright © 2008 by The American Society for Cell Biology. Terms of copyright protection, warranties, and disclaimers.